Address And Details

40 East 52nd Street , New York, NY 10022
Fund Manager Andrew Wheatley Hubbard
Manager Tenure 5 Years 7 Months

Strategy And Objective

The investment objective of the BlackRock Long-Horizon Equity Fund (the Fund ) is to provide high total investment return. The Fund seeks to achieve its investment objective through a fully managed investment policy utilizing global equity securities. The Fund will, under normal circumstances, invest at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities. Equity securities include common stock, preferred stock, convertible securities, warrants, and securities or other instruments whose price is linked to the value of common stock. The combination of equity securities will be varied from time to time both with respect to types of securities and markets and in response to changing market and economic trends. In making investment decisions, Fund management conducts bottom-up, company-specific, research to identify stocks it believes have the potential to produce attractive total returns over a long-term investment horizon. In selecting equity investments, the Fund mainly seeks securities that Fund management believes are undervalued. When choosing investments, Fund management considers various factors, including opportunities for equity investments to increase in value, expected dividends, and interest rates. The Fund may invest in the securities of companies of any market capitalization. The Fund may invest a portion of its assets in securities directly or indirectly secured by real estate or interests therein or issued by companies that invest in real estate or interests therein such as stock, bonds or convertible bonds issued by real estate investment trusts ( REITs ). The Fund may use derivatives, including options, futures, swaps and forward contracts both to seek to increase the return of the Fund and to hedge (or protect) the value of its assets against adverse movements in currency exchange rates, interest rates, and movements in the securities markets. The Fund may invest in indexed and inverse securities. The Fund has no geographic limits on where it may invest. The Fund may invest in both developed and emerging markets. When choosing investment markets, Fund management considers various factors, including economic and political conditions, potential for economic growth and possible changes in currency exchange rates. In addition to investing in foreign securities, the Fund actively manages its exposure to foreign currencies through the use of forward currency contracts and other currency derivatives. The Fund may own foreign cash equivalents or foreign bank deposits as part of the Fund s investment strategy. The Fund may invest in non-U.S. currencies. The Fund may underweight or overweight a currency based on the Fund management team s outlook. In addition to its 80% policy set out above, the Fund may invest up to 20% of its net assets (plus any borrowings for investment purposes) in cash investments if prospective equity returns are expected to be unattractive. Furthermore, for temporary defensive purposes and in case of unusually large cash inflows or redemptions, the Fund may invest without limitation in cash, cash equivalents, money market securities, such as U.S. Treasury and agency obligations, other U.S. Government securities, short term debt obligations of corporate issuers, certificates of deposit, bankers acceptances, commercial paper (short term, unsecured, negotiable promissory notes of a domestic or foreign issuer) or other high quality fixed-income securities.

Net Asset Value

as of 5:05 PM ET 09/17/2021


  • 1 Week
  • +0.20%
  • 1 Month
  • +1.55%
  • 3 Months
  • -11.07%
  • 1 Yr Return
  • +8.91%
  • 5 Yr Return
  • +34.68%

Equity Sector Breakdown

Finance 28.34%
Technology 28.22%
NonDurables 11.52%
IndustrialCyclical 5.98%
RetailTrade 5.66%
ConsumerDurables 5.53%
Health 4.43%
Utilities 3.89%
Services 3.45%
Energy n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 99.90%
ForeignStocks 29.91%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 1.88 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 1.30 -0.64 -4.65
Beta 0.94 0.93 0.98
R Squared 0.95 0.90 0.89
Std Deviation 17.84 14.76 13.93
Sharpe Ratio 1.07 1.09 n/a

Purchase Information

as of 5:02 PM ET 09/16/2021
Minimum Initial $1000
Minimum Additional $50
Minimum Initial IRA $0


Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +32.41%
  • +45.06%
+32.41% +45.06%
3 Year
  • +18.51%
  • +18.75%
+18.51% +18.75%
10 Year
  • +10.54%
  • +9.30%
+10.54% +9.30%
Life Of Fund
  • +8.36%
  • +8.16%
+8.36% +8.16%

Top 10 Holdings

Symbol Company Name % Of Assets

Recent Articles from TheStreet

Adobe Lead

Adobe Initiates at Overweight by Wells Fargo

Adobe is 'one of the crown jewels of software,' a Wells Fargo analyst says.

Bitcoin Down Lead

Bitcoin Gets Blasted, But Should You Buy the Dip or Wait?

Bitcoin prices are getting smashed on Monday. So far support is holding, but is it dependable enough to buy? Let's look at the chart.

Nasdaq-listed Chinese Electric Carmaker Li Auto Apologises For Passing Off Recall Of 10,469 Li ONEs As 'upgrade' Offer

Chinese EV Maker Li Cuts Delivery Forecast, Shares Fall

Li trims its forecast to 24,500 vehicle deliveries for the third quarter from 25,000 to 26,000.

Toys 'R' Us Sells FAO Schwarz as it Reveals Further Debt Refinancing Plans

Toymakers Facing Holiday Challenge Due to Supply-Chain Issues

Supply-chain issues could make this Christmas season more challenging than normal for toymakers, a media report says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Twitter Blue Lead

Twitter to Pay $810M to Settle Holder Suit Over User Engagement

Twitter's payment would settle a shareholder lawsuit that the company misled investors about its user engagement totals.

Starboard Takes Stake in CVS Health Corp.: Report

CVS to Add 25,000 Workers Ahead of Flu Season, Covid Booster Shots

Pharmacy giant CVS plans to add 25,000 ahead of flu season and coronavirus-related vaccinations.

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.